DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) will host an Analyst and Investor Conference in New York City on Wednesday, November 8, 2017. Management will provide an update on the business and progress since the merger. The presentations will begin at 9:00 a.m. ET and will conclude at approximately 1:00 p.m. Registration is required to attend the event.
All are invited to listen to the live event and view the presentation slides via webcast on the QuintilesIMS Investor Relations website at http://ir.quintilesims.com. The discussion will also be available by dialing +1-800-672-6112 in the U.S. and Canada, or +1-303-223-4370 for international callers.
A replay of the webcast will be available later that day, following the conclusion of the live event. To access the webcast recording, visit http://ir.quintilesims.com.
QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.
As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, and to identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com.